Cargando…
Long-Term Anticoagulation in Secondary Ischemic Stroke Prevention: The Prospective Multicenter RESTAIC Registry
Background and Objective: Oral anticoagulation (OAC) for secondary stroke prevention is recommended in atrial fibrillation (AF) and other sources of cardioembolic stroke. Our objectives were to explore the differences in ischemic and hemorrhagic events when using OAC for secondary stroke prevention...
Autores principales: | Gutiérrez-Zúñiga, Raquel, Rigual, Ricardo, Torres-Iglesias, Gabriel, Sánchez-Velasco, Sara, Alonso de Leciñana, María, Masjuan, Jaime, Álvarez Velasco, Rodrigo, Navas, Inmaculada, Izquierdo-Esteban, Laura, Fernández-Ferro, José, Rodríguez-Pardo, Jorge, Ruiz-Ares, Gerardo, Zapata-Wainberg, Gustavo, Fuentes, Blanca, Díez-Tejedor, Exuperio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641639/ https://www.ncbi.nlm.nih.gov/pubmed/33193025 http://dx.doi.org/10.3389/fneur.2020.575634 |
Ejemplares similares
-
Biochemical and inflammatory biomarkers in ischemic stroke: translational study between humans and two experimental rat models
por: Martínez-Sánchez, Patricia, et al.
Publicado: (2014) -
A New Software for Quantifying Motor Deficit After Stroke: A Case–Control Feasibility Pilot Study
por: Gutiérrez Zúñiga, Raquel, et al.
Publicado: (2021) -
The use of a smartphone application to improve stroke code workflow
metrics: A pilot study in a comprehensive stroke centre
por: Gutiérrez-Zúñiga, Raquel, et al.
Publicado: (2022) -
It's Time to Say Goodbye to the ESUS Construct
por: Fuentes, Blanca, et al.
Publicado: (2020) -
Final Results of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells in Acute Ischemic Stroke (AMASCIS): A Phase II, Randomized, Double-Blind, Placebo-Controlled, Single-Center, Pilot Clinical Trial
por: de Celis-Ruiz, Elena, et al.
Publicado: (2022)